352 related articles for article (PubMed ID: 31704276)
1. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice.
Wang X; Chang Y; He Y; Lyu C; Li H; Zhu J; Liu K; Hu Y; Huang K; Pan S
Neuropharmacology; 2020 Jan; 162():107845. PubMed ID: 31704276
[TBL] [Abstract][Full Text] [Related]
2. SUR1-TRPM4 channels, not K
Woo SK; Tsymbalyuk N; Tsymbalyuk O; Ivanova S; Gerzanich V; Simard JM
Neurosci Lett; 2020 Jan; 718():134729. PubMed ID: 31899311
[TBL] [Abstract][Full Text] [Related]
3. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
4. Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.
Wilkinson CM; Brar PS; Balay CJ; Colbourne F
PLoS One; 2019; 14(5):e0215952. PubMed ID: 31042750
[TBL] [Abstract][Full Text] [Related]
5. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage.
Jiang B; Li L; Chen Q; Tao Y; Yang L; Zhang B; Zhang JH; Feng H; Chen Z; Tang J; Zhu G
Transl Stroke Res; 2017 Apr; 8(2):183-193. PubMed ID: 27807801
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats.
Wu Z; Zhu SZ; Hu YF; Gu Y; Wang SN; Lin ZZ; Xie ZS; Pan SY
Brain Res; 2016 Jul; 1643():113-22. PubMed ID: 27134036
[TBL] [Abstract][Full Text] [Related]
7. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
[TBL] [Abstract][Full Text] [Related]
8. Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus.
Lin Z; Huang H; Gu Y; Huang K; Hu Y; Ji Z; Wu Y; Wang S; Yang T; Pan S
Neuropharmacology; 2017 Jul; 121():1-11. PubMed ID: 28412320
[TBL] [Abstract][Full Text] [Related]
9. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest.
Nakayama S; Taguchi N; Isaka Y; Nakamura T; Tanaka M
Neurocrit Care; 2018 Aug; 29(1):119-127. PubMed ID: 29150777
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia.
He Y; Chang Y; Peng Y; Zhu J; Liu K; Chen J; Wu Y; Ji Z; Lin Z; Wang S; Gupta S; Zang N; Pan S; Huang K
Mol Neurobiol; 2022 Oct; 59(10):6590-6607. PubMed ID: 35972671
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.
Simard JM; Yurovsky V; Tsymbalyuk N; Melnichenko L; Ivanova S; Gerzanich V
Stroke; 2009 Feb; 40(2):604-9. PubMed ID: 19023097
[TBL] [Abstract][Full Text] [Related]
13. Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts.
Mehta RI; Tosun C; Ivanova S; Tsymbalyuk N; Famakin BM; Kwon MS; Castellani RJ; Gerzanich V; Simard JM
J Neuropathol Exp Neurol; 2015 Aug; 74(8):835-49. PubMed ID: 26172285
[TBL] [Abstract][Full Text] [Related]
14. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
Jha RM; Bell J; Citerio G; Hemphill JC; Kimberly WT; Narayan RK; Sahuquillo J; Sheth KN; Simard JM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936452
[TBL] [Abstract][Full Text] [Related]
15. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
Caffes N; Kurland DB; Gerzanich V; Simard JM
Int J Mol Sci; 2015 Mar; 16(3):4973-84. PubMed ID: 25749474
[TBL] [Abstract][Full Text] [Related]
16. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
[TBL] [Abstract][Full Text] [Related]
17. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
Tosun C; Kurland DB; Mehta R; Castellani RJ; deJong JL; Kwon MS; Woo SK; Gerzanich V; Simard JM
Stroke; 2013 Dec; 44(12):3522-8. PubMed ID: 24114458
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.
Zhou Y; Fathali N; Lekic T; Tang J; Zhang JH
Brain Res; 2009 May; 1270():131-9. PubMed ID: 19306849
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats.
Kung TFC; Wilkinson CM; Dirks CA; Jickling GC; Colbourne F
PLoS One; 2021; 16(6):e0252584. PubMed ID: 34081746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
